Mechanisms of Gait Asymmetry Due to Push-Off Deficiency in Unilateral Amputees.
Peter Gabriel Adamczyk, Arthur D Kuo
https://pubmed.ncbi.nlm.nih.gov/25222950/Actively Recruiting
Led by Shirley Ryan AbilityLab · Updated on 2024-05-30
20
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to understand how providing powered assistance at the knee or ankle, individually or combined, affects walking ability in people with K2 level transfemoral amputations. The study evaluates functional performance using both commercially available passive prosthetic devices and experimental powered prostheses, focusing on improvements in mobility and energy efficiency. Researchers also assess the impact of intensive clinical gait training on using powered knee and ankle prostheses for these amputees. Participants will use different prosthetic devices during various study phases. Initially, they will be fitted with a commercial passive microprocessor knee and foot and receive clinical training over 4 weeks. Then, they will use an experimental powered knee and ankle prosthesis with similar training. Another phase involves a randomized crossover comparing powered knee with passive ankle and passive knee with powered ankle devices, including device tuning and outcome assessments. Finally, participants undergo intensive clinical training with the powered knee and ankle prosthesis twice weekly for 8 weeks, followed by functional testing. During the study, participants will attend multiple visits to complete functional outcome tests such as the Amputee Mobility Predictor, 6 Minute Walk Test, Timed Up and Go, Four Square Step Test, and metabolic assessments at specified weeks. Training sessions will focus on individualized therapy goals and mobility skills. The study monitors changes in walking function, energy use, and overall mobility with different prosthetic setups over time, involving a total participation duration extending up to 38 weeks.
CONDITIONS
Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait
S
Suzanne Finucane, MS, PTA
L
Levi Hargrove, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Shirley Ryan AbilityLab
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Hybrid powered knee and powered ankle | Hybrid powered knee with passive ankle | Standard microprocessor-controlled knee + passive ankle |
|---|---|---|---|
| What it is | A crossover condition in the trial using the SRALAB Hybrid powered knee combined with a powered polycentric ankle prosthesis. | A crossover condition using the SRALAB Hybrid powered knee with a passive ankle joint. | Typical prosthetic configuration uses a microprocessor-controlled knee (e.g. C‑Leg) paired with a passive ankle‑foot prosthesis. |
| Role in trial | Crossover condition tested in sequence alongside other configurations. | Crossover condition compared to other prosthetic configurations in same participants. | This column is not a trial arm but provides the external clinical benchmark for comparison. |
| Purpose / Primary use | Evaluate gait performance when both knee and ankle are powered. | Assess effect of powered knee alone while ankle remains passive. | Represents current standard for enabling walking mobility in transfemoral amputees. |
| How it is worn or used | Participants wear the powered knee and powered ankle prosthesis during gait evaluation periods throughout crossover visits. | Participants wear powered knee with passive ankle prosthesis during visits in crossover design. | Users typically use a microprocessor knee and passive ankle-foot system as their daily prosthesis. |
| Evidence status | No published study yet; trial is ongoing to evaluate performance outcomes. | Currently under investigation; outcomes not yet available. | MPKs with passive ankles have demonstrated improvements in balance, reduced falls and enhanced gait performance in transfemoral amputees. |
| Important risks | Safety and tolerability are being evaluated; specific risks are not yet reported. | Safety under investigation; device risks not yet known. | MPKs have documented safety improvements such as reduced falls and stumbles compared to non-microprocessor knees. |
| Important limitations | Unknown generalizability; small sample size and single‑center crossover design may limit broader applicability. | Experimental configuration lacks long‑term use data and may require adaptation period. | Passive ankle lacks powered propulsion, limiting adaptability on uneven terrain or slopes compared to powered designs. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 to 8 weeks depending on device and training schedule
Participants are fitted with different prosthetic devices including commercially available and experimental powered prostheses in a randomized crossover design.
2 to 4 training sessions over 4 weeks or twice weekly sessions over 8 weeks depending on assignment, plus outcome assessment visits
Duration - Up to 38 weeks with multiple assessment visits
Participants complete functional outcome measures, biomechanical and metabolic assessments to evaluate the impact of the prosthetic devices on gait and mobility.
Multiple visits for outcome assessments during weeks 5, 10, 11, 14, 15, 18, 35, and 38
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Peter Gabriel Adamczyk, Arthur D Kuo
https://pubmed.ncbi.nlm.nih.gov/25222950/Kathryn Ziegler-Graham, Ellen J MacKenzie, Patti L Ephraim...
https://pubmed.ncbi.nlm.nih.gov/18295618/H Burger, C Marincek
https://pubmed.ncbi.nlm.nih.gov/9141124/R S Gailey, M A Wenger, M Raya...
https://pubmed.ncbi.nlm.nih.gov/7991365/Brian J Hafner, Joan E Sanders, Joseph Czerniecki...
https://pubmed.ncbi.nlm.nih.gov/12084537/Nicholas P Fey, Ann M Simon, Aaron J Young...
https://pubmed.ncbi.nlm.nih.gov/27170878/Shirley Ryan AbilityLab
Lead Sponsor